Epigenomics improves every stage of drug discovery
Chromatin mapping assays like CUT&RUN reveal regulatory mechanisms controlling gene expression that transcriptional profiling alone cannot show. This insight helps identify new therapeutic targets and investigate treatment resistance.
- Field
- genetics and genomes
- What they did
- Researchers are studying epigenomic methods, such as chromatin mapping, to understand gene regulation mechanisms that are invisible when analyzing only the DNA sequence.
- Why it matters
- This enables the identification of novel therapeutic targets and the explanation of how drugs work, which is critical for developing new medicines.
#epigenomics#drug discovery#chromatin mapping#cut&run#gene regulation



